Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 10,876
Sort by:

Reflux Esophagitis (Gastroesophageal Reflux) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Reflux Esophagitis (Gastroesophageal Reflux) PIPELINE HIGHLIGHTS Reflux Esophagitis (Gastroesophageal Reflux) is one of the widely researched conditions during 2020 with 18 companies actively foc...

July 2020 98 pages

Restenosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Restenosis PIPELINE HIGHLIGHTS Restenosis is one of the widely researched conditions during 2020 with 2 companies actively focusing on realizing pipeline’s potential. Development of Restenosis me...

July 2020 32 pages

Rosacea pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Rosacea PIPELINE HIGHLIGHTS Rosacea is one of the widely researched conditions during 2020 with 21 companies actively focusing on realizing pipeline’s potential. Development of Rosacea medicines...

July 2020 104 pages

Scar pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Scar PIPELINE HIGHLIGHTS Scar is one of the widely researched conditions during 2020 with 13 companies actively focusing on realizing pipeline’s potential. Development of Scar medicines is identi...

July 2020 72 pages

Seborrhea pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Seborrhea PIPELINE HIGHLIGHTS Seborrhea is one of the widely researched conditions during 2020 with 4 companies actively focusing on realizing pipeline’s potential. Development of Seborrhea medic...

July 2020 42 pages

Secondary Hyperparathyroidism pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Secondary Hyperparathyroidism PIPELINE HIGHLIGHTS Secondary Hyperparathyroidism is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s p...

July 2020 51 pages

Short Bowel Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Short Bowel Syndrome PIPELINE HIGHLIGHTS Short Bowel Syndrome is one of the widely researched conditions during 2020 with 12 companies actively focusing on realizing pipeline’s potential. Develop...

July 2020 72 pages

Sinusitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Sinusitis PIPELINE HIGHLIGHTS Sinusitis is one of the widely researched conditions during 2020 with 20 companies actively focusing on realizing pipeline’s potential. Development of Sinusitis medi...

July 2020 106 pages

Systemic Mastocytosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Systemic Mastocytosis PIPELINE HIGHLIGHTS Systemic Mastocytosis is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s potential. Develo...

July 2020 74 pages

Thalassemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Thalassemia PIPELINE HIGHLIGHTS Thalassemia is one of the widely researched conditions during 2020 with 37 companies actively focusing on realizing pipeline’s potential. Development of Thalassemi...

July 2020 145 pages

Thromboembolism pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Thromboembolism PIPELINE HIGHLIGHTS Thromboembolism is one of the widely researched conditions during 2020 with 19 companies actively focusing on realizing pipeline’s potential. Development of Th...

July 2020 117 pages

Thrombotic Thrombocytopenic Purpura (Moschcowitz) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Thrombotic Thrombocytopenic Purpura (Moschcowitz) PIPELINE HIGHLIGHTS Thrombotic Thrombocytopenic Purpura (Moschcowitz) is one of the widely researched conditions during 2020 with 4 companies act...

July 2020 40 pages

Tinnitus pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Tinnitus PIPELINE HIGHLIGHTS Tinnitus is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Tinnitus medicine...

July 2020 52 pages

Urinary Incontinence pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Urinary Incontinence PIPELINE HIGHLIGHTS Urinary Incontinence is one of the widely researched conditions during 2020 with 15 companies actively focusing on realizing pipeline’s potential. Develop...

July 2020 65 pages

Vaso-Occlusive Crisis Associated With Sickle Cell Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Vaso-Occlusive Crisis Associated With Sickle Cell Disease PIPELINE HIGHLIGHTS Vaso-Occlusive Crisis Associated With Sickle Cell Disease is one of the widely researched conditions during 2020 with...

July 2020 64 pages

Venous Leg Ulcers (Crural ulcer) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Venous Leg Ulcers (Crural ulcer) PIPELINE HIGHLIGHTS Venous Leg Ulcers (Crural ulcer) is one of the widely researched conditions during 2020 with 12 companies actively focusing on realizing pipel...

July 2020 71 pages

Ventricular Tachycardia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Ventricular Tachycardia PIPELINE HIGHLIGHTS Ventricular Tachycardia is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s potential. De...

July 2020 51 pages

Vitiligo pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Vitiligo PIPELINE HIGHLIGHTS Vitiligo is one of the widely researched conditions during 2020 with 19 companies actively focusing on realizing pipeline’s potential. Development of Vitiligo medicin...

July 2020 134 pages

Xerostomia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Xerostomia PIPELINE HIGHLIGHTS Xerostomia is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development of Xerostomia me...

July 2020 40 pages

COVID Treatment and Vaccine Drug Pipeline Report- July 2020 Update

US$ 2,609.00

COVID-19 condition is currently one of the most researched diseases across the world and presents a robust pipeline with more than 300 companies participating in COVID treatment and COVID vaccine deve...

July 2020 170 pages

Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2029)

US$ 1,700.00

Non-alcoholic Steatohepatitis or NASH is a common term for “silent” liver disease and can result ... disease and the local companies engaged in the manufacturing of NASH drugs. The report “Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Industry Analysis & Outlook (2018-2027)” by Koncept Analytics ...

July 2020 102 pages

Global Leukemia Drug Market, Drug Price, Patent, Dosage & Clinical Trials Insight 2025

US$ 4,800.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. 'Global Leukemia Drug Market, Drug Price, Patent, Dosage & Clinical Trials Insight 2025'...

July 2020 1740 pages

Global Antihypertensive Drugs Market Size study, by Therapeutic Class (Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2020-2027

US$ 3,750.00

Global Antihypertensive Drugs Market is valued at approximately USD 23.2 million in 2019 and is anticipated to grow with a healthy growth rate of more than 3.1% over the forecast period 2020-2027. Ant...

June 2020 200 pages

Protein Crystallization & Crystallography Market by Technology (NMR, X-Ray Crystallography), Product & Service (Instrument (Liquid Handling (Automated)), Consumable (Reagent, Microplate) End User, and Region - Global Forecast to 2025

US$ 2,970.00

... market for protein crystallization & crystallography is expected to grow at a high rate owing to its huge potential in drug discovery and development. This research report categorizes the protein crystallization & crystallography market on the basis of technologies (protein purification, protein crystallization, protein crystal mounting, and protein crystallography), products (analyzers and reagents), and end ...

June 2020 148 pages

Asia Pacific Osteoporosis Drugs Market By Route of Administration (Oral, Injectable and Other Route of Administration) By Drug Class (Bisphosphonates, Rank Ligand Inhibitors, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM) and Other Drug Classes) By Country, Industry Analysis and Forecast, 2020 - 2026

US$ 1,500.00

The Asia Pacific Osteoporosis Drugs Market would witness market growth of 5.6% CAGR during the forecast period (2020-2026). The Asia Pacific market is expected to rise in the coming years in a lucrati...

May 2020 79 pages

Europe Osteoporosis Drugs Market By Route of Administration (Oral, Injectable and Other Route of Administration) By Drug Class (Bisphosphonates, Rank Ligand Inhibitors, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM) and Other Drug Classes) By Country, Industry Analysis and Forecast, 2020 - 2026

US$ 1,500.00

The Europe Osteoporosis Drugs Market would witness market growth of 4% CAGR during the forecast period (2020-2026). Growth in the market for osteoporosis drugs is likely to be delayed due to side effe...

May 2020 79 pages

Global Osteoporosis Drugs Market By Route of Administration (Oral, Injectable and Other Route of Administration) By Drug Class (Bisphosphonates, Rank Ligand Inhibitors, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM) and Other Drug Classes) By Region, Industry Analysis and Forecast, 2020 - 2026

US$ 3,600.00

The Global Osteoporosis Drugs Market size is expected to reach $10.9 billion by 2026, rising at a market growth of 4.4% CAGR during the forecast period. Osteoporosis is defined as a medical condition...

May 2020 173 pages

LAMEA Osteoporosis Drugs Market By Route of Administration (Oral, Injectable and Other Route of Administration) By Drug Class (Bisphosphonates, Rank Ligand Inhibitors, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM) and Other Drug Classes) By Country, Industry Analysis and Forecast, 2020 - 2026

US$ 1,500.00

The Latin America, Middle East and Africa Osteoporosis Drugs Market would witness market growth of 5.3% CAGR during the forecast period (2020-2026). Vitamin D deficiency is prevalent in the Middle Eas...

May 2020 79 pages

North America Osteoporosis Drugs Market By Route of Administration (Oral, Injectable and Other Route of Administration) By Drug Class (Bisphosphonates, Rank Ligand Inhibitors, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM) and Other Drug Classes) By Country, Industry Analysis and Forecast, 2020 - 2026

US$ 1,500.00

The North America Osteoporosis Drugs Market would witness market growth of 3.7% CAGR during the forecast period (2020-2026). Osteoporosis is the degradation of bones owing to reduced bone density resu...

May 2020 73 pages

Global Antiviral Drugs Market (By Type, Application & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

US$ 1,250.00

The global antiviral drugs market is expected to reach US$70.95 billion in 2024, increasing at a CAGR of 2.10%, for the duration of 2020-2024. The factors such as, increasing prevalence of HIV infecti...

May 2020 121 pages

COVID 19 Drug and Vaccine Pipeline Current Status Report: May 2020 Update

US$ 2,609.00

The May 2020 updated COVID-19 pipeline report presents most recent updates on drug candidates and vaccine candidates that will potentially reach the market in the next 2 years. As of May 2020, the CO...

May 2020 137 pages

COVID-19 Impact on Vaccines & Drugs Market - Global Forecast to 2025

US$ 2,970.00

'The global COVID 19 vaccines market is projected to grow at a CAGR of -14.9% during the forecast period.' The global COVID-19 vaccines market is projected to reach USD 1,401 million by 2025 from USD...

May 2020 67 pages

Global Antibody Drug Conjugates Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

US$ 3,950.00

Value Market Research’s latest report on the Global Antibody Drug Conjugates Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably with...

May 2020 165 pages

Global Epigenetics Drugs And Diagnostic Technologies Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

US$ 3,950.00

Value Market Research’s latest report on the Global Epigenetics Drugs And Diagnostic Technologies Market identified a significant growth in the industry over the last few years and anticipates it to g...

May 2020 125 pages

Global Gummy Vitamin Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2019 to 2026

US$ 3,950.00

Value Market Research’s latest report on the Global Gummy Vitamin Market identified a significant growth in the industry over the last few years and anticipates it to grow considerably within the fore...

May 2020 90 pages

Global Paracetamol Market Size study, by Form (Tablet, Liquid Suspension, Capsule, and Other Forms), by Route of Administration (Oral, Rectal and Intravenous) and Regional Forecasts 2020-2026

US$ 3,750.00

Global Paracetamol Market is valued approximately at USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. Paracetamol, also...

May 2020 200 pages

Report Package: “Drug the Undruggable” Technologies

US$ 4,700.00

Report Package: “Drug the Undruggable” Technologies This report package includes four full reports for the price of two: Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a land...

May 2020 -

Global Vaccine and Drugs Market Size study with COVID-19 Impact, by Type (Vaccine, Drugs) by End-Use (Hospitals, Clinics, Others) and Regional Forecasts 2020-2026

US$ 3,750.00

Global Vaccine and Drugs Market is valued approximately at USD XXX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2020-2026. Vaccines...

May 2020 200 pages

Global Anti-Malarial Drugs Market (by Drug Type, Anti-Malarial Activity, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

US$ 1,200.00

The global anti-malarial drugs market is expected to reach US$1035.39 million in 2024, witnessing growth at a CAGR of 3.09%, over the period 2020-2024. Factors such as rising healthcare expenditure, i...

April 2020 122 pages

Global Anticoagulant Reversal Drugs Market Size study, by Drug Class (Prothrombin Complex Concentrates, Coagulation Factors, Monoclonal Antibodies, Phytonadione and Others), and Regional Forecasts 2020-2026

US$ 3,750.00

Global Anticoagulant Reversal Drugs Market is valued approximately at USD 811.56 Million in 2019 and is anticipated to grow with a healthy growth rate of more than 15.6% over the forecast period 2019-...

April 2020 200 pages

Global Roadside Drug Testing Devices Market Size study, by Type (Breathalyzer, Intoxilyzer), by Substances (Drugs, Alcohol), by Sample Type (Saliva, Sweat, Urine, Others), by End-Users (Highway Police, Drug Enforcement Agencies, Others) and Regional Forecasts 2020-2026

US$ 3,750.00

Global Roadside Drug Testing Devices Market is valued approximately at USD 999.4 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.0% over the forecast period 2020-2...

April 2020 200 pages

Global Vitamin D Testing Market Size study, by Vitamin Type (Vitamin D2, Vitamin D3), by Application (Functional Food & Beverage, Pharmaceuticals, Animal Feed & Pet Food and Personal care), by End-User (Pediatrics, Adults, Geriatric and Pregnant Women) and Regional Forecasts 2020-2026

US$ 3,750.00

Global Vitamin D Testing Market is valued approximately at USD 0.64 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 9.40 % over the forecast period 2019-2026. Vitami...

April 2020 200 pages

2020 COVID 19 Drug Pipeline Report- Current Status, Phase, Companies, Pre-Clinical And Clinical Drugs

US$ 2,609.00

The 2020 COVID-19 pipeline report presents a comprehensive overview of the research and development of COVID drug candidates. It presents drugs in development that could potentially reach the market i...

March 2020 80 pages

Filters

Search

Publishers

1
450
353
174
29
4
837
409
36
27
2,279
77
19
16
2
21
1
16
1
9
9
2,264
5
4
31
6
142
1
17
15
248
651
91
1
373
26
34
724
1
2
16
6
4
84
36
3
4
2
7
15
53
16
26
83
11
32
8
2
17
106
27
19
4
7
3
324
15
1
23
86
24
28
44
296
17
18
2

Regions

131
40
38
37
37
35
32
23
13
10
10
9
9
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
5
5
5
5
4
4
3
3
3
3
3
91
12
354
30
6
6
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
39
6
4
3
3
3
1
1
3
7
9,529

Price

—

Date

—

Pages

—

Offers

9
1